Pharmacy
Initial data shows that a third dose of its vaccine boosted antibody levels to a higher degree than the previous round.
Dr. Brian Covino, chief medical officer at Cohere Health, talks about reducing payer and provider friction and the CMS' proposed rule on prior authorizations.
For Arizona's HonorHealth, distributing the COVID-19 vaccine was more about using what already existed.
This week's top stories include Dr. David Feinberg leaving Google Health to serve as Cerner's CEO as Google dismantles its health division, and the FDA giving full approval to the Pfizer/BioNTech COVID-19 vaccine.
The policy is meant to ensure that at-risk patients in smaller settings have the same opportunities as others to receive the vaccination.
Based on results from the clinical trial, the vaccine was 91% effective in preventing COVID-19 disease.
The boosters are subject to FDA review and the CDC's Advisory Committee on Immunization Practices issuing a recommendation.
This includes employees who work remotely, though the organization will allow individuals to apply for a medical or religious exemption.
Both Pfizer and Moderna are in clinical trials for vaccines for children under the age of 12.
Both Pfizer and Moderna have received amended EUAs to give a third shot to individuals with weakened immune systems.